PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F20Q9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,151
Award facts
- Contract value 100% obligated
- $14,151.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,151.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle serves as a global pharmaceutical support mechanism enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills an essential role in supporting Defense Health Agency operations and other government healthcare systems. The company's portfolio of federal contract awards demonstrates extensive capability in delivering diverse pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. As a leading vendor in the DLA's Pharmaceutical Prime Vendor program, AmerisourceBergen competes successfully in open procurement processes and maintains the flexibility to serve military and veteran healthcare systems through its comprehensive contract vehicle, which positions it as one of several anticipated multiple-award recipients for the upcoming Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2D825F20Q9?
SPE2D825F20Q9 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2D825F20Q9 worth?
The government has obligated $14,151 on SPE2D825F20Q9.
Is contract SPE2D825F20Q9 an order under another contract?
Yes. SPE2D825F20Q9 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D825F20Q9 competed?
The extent of competition for SPE2D825F20Q9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award